After I finished my DD, I see the drug did real good in phase I, II and chances are high that it will bring some good result when tested on much larger population in phase III. Interim data from phase III could come anytime and a good result could push this stock with a similar percentile gain as it happened in ICPT.
that's fine but do you have any idea on the efficacy of the drug in phase II? Do you know any link where I could find something on it? thanks in advance.
Technically it's sitting on a break-point, any phase III positive news would push it lot higher.
Sentiment: Strong Buy
Past few days trading pattern:
hits intra-day high, closed little below HOD. Next day new HOD and closed previous day's HOD (lower). Pattern repeats. Tomorrow we night see $1.08 HOD and close at $1.04.
Big days ahead...
get a DD on SVNT... going to skyrocket and could be the biotech of 2012. Loading all SVNT under a buck. SVNT was at $22 in 2009 and will go back there in next 12 to 18 months or earlier IMHO